Trademark: 87951452
Status Date
Monday, August 23, 2021
Filing Date
Wednesday, June 6, 2018
Published for Opposition
Tuesday, November 27, 2018
Abandoned Date
Monday, August 23, 2021
5 pharmaceuticals, namely, bio-pharmaceuticals for the treatment of cancer
42 Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; Research and development of bio-pharmaceuticals for the treatment of cancer
44 cancer treatment services; oncolytic virotherapy services
Aug 23, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 23, 2021
Abandonment - No Use Statement Filed
Jan 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 19, 2021
Extension 4 Granted
Jan 19, 2021
Extension 4 Filed
Jan 19, 2021
Teas Extension Received
Jul 21, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 17, 2020
Extension 3 Granted
Jul 17, 2020
Extension 3 Filed
Jul 17, 2020
Teas Extension Received
Jan 16, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2020
Extension 2 Granted
Jan 14, 2020
Extension 2 Filed
Jan 14, 2020
Teas Extension Received
Jul 17, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 15, 2019
Extension 1 Granted
Jul 15, 2019
Extension 1 Filed
Jul 15, 2019
Teas Extension Received
Jan 22, 2019
Noa E-Mailed - Sou Required From Applicant
Nov 27, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 27, 2018
Published For Opposition
Nov 7, 2018
Notification Of Notice Of Publication E-Mailed
Oct 25, 2018
Law Office Publication Review Completed
Oct 21, 2018
Assigned To Lie
Oct 9, 2018
Approved For Pub - Principal Register
Oct 1, 2018
Examiner's Amendment Entered
Oct 1, 2018
Notification Of Examiners Amendment E-Mailed
Oct 1, 2018
Examiners Amendment E-Mailed
Oct 1, 2018
Examiners Amendment -Written
Sep 24, 2018
Assigned To Examiner
Jun 13, 2018
New Application Office Supplied Data Entered In Tram
Jun 9, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
